SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
The delays, first revealed in Regeneron’s Q2 report, were chalked up to manufacturing issues at Novo Nordisk-owned plants.
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Photo of Boston, Massachusetts, at the Boston Harbor and Financial District with a mix of contemporary and historic architecture.
Job Trends
9 Companies Hiring Now in Massachusetts
Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
August 21, 2025
 · 
1 min read
 · 
Chantal Dresner
Red rocket with clouds rising up as metaphor for business and financial growth, Success and financial developing, Business growth concept, paper cut style.
Gene therapy
Rocket Re-Ignites Phase II Trial After FDA Lifts Clinical Hold
In late May, a patient died after receiving Rocket Pharmaceuticals’ investigational gene therapy for Danon disease, spurring the hold. After lowering the dose and changing the regimen of immune modulators patients receive, the company has received FDA clearance for the trial to continue.
August 20, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Cancer
FDA Looks To Raise Survival Bar for Cancer Drug Approvals in New Draft Guidance
The FDA recommends that companies use overall survival as a primary endpoint for clinical trials where feasible. The new guidance follows the surprising return of CBER Head Vinay Prasad, who has previously argued for prioritizing OS.
August 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Arrows lead to a graph of a downward trend, then c
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.
August 20, 2025
 · 
1 min read
 · 
Tristan Manalac
Pill coming out of jar forms a price increase graph. Cost of drugs on the rise. Healthcare costs and the high price of quality health care insurance concept. The cost of pills and tablets increasing. Vector illustration
Opinion
Look to Competition, Not Mandates, to Lower Drug Prices
Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.
August 20, 2025
 · 
4 min read
 · 
Kirsten Axelsen
Healthcare, medical and doctor with kid patient and father holding baby for shot in hospital. Girl, children and family clinic nurse with vaccine for covid, virus or flu shot.
Vaccines
American Academy of Pediatrics Contradicts CDC, Recommends COVID-19 Shot for Kids
The CDC no longer recommends COVID-19 vaccines for healthy children and healthy pregnant women, a position that has been opposed by leading medical societies.
August 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
A draft copy of an upcoming MAHA report reveals a strategy in lockstep with recent HHS actions such as reviving the Task Force on Safer Childhood Vaccines; Viking Therapeutics reports robust efficacy from mid-stage oral obesity candidate but is tripped up by tolerability concerns; Novo Nordisk wins approval for Wegovy in MASH; and Lilly takes a pricing stand.
August 20, 2025
 · 
2 min read
 · 
Heather McKenzie
Illustration showing conversation during interview
Career Advice
Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews
Media coverage can help biopharma executives connect with, inform and inspire the public. In this column, Kaye/Bassman’s Michael Pietrack and three communications experts share how to make the most of these opportunities.
August 20, 2025
 · 
6 min read
 · 
Michael Pietrack
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS